MEETMUSA Accelerating the iMpact of microsurgEry by upscaling production of thE world’s first microsurgical roboT: MUSA
- Coordinator
- Microsure BV, Netherlands
- Runs
- 1 January 2022 to 30 April 2024
- Status
- Finished
- EU funding
- €1.8m
- Total cost
- €2.6m
- Partners
- 1 organisations in 1 countries
- Type
- European Innovation Council
- Grant agreement
- 190126849
What the project is doing
In the project's own words, from its summary on CORDIS.
The revolution in microsurgery is here. Microsure, a highly innovative Dutch medical device company is introducing MUSA, the worlds first clinically available CE-certified microsurgical robot. We will maximize microsurgical performance by offering superhuman precision and comfort through robotic assistance in pursuit of excellence for both patients and health providers. The MUSA robot is highly efficient thereby reducing costs and improving access to microsurgical procedures.
With the great unmet need in microsurgery, we are convinced that the timing for market introduction of MUSA is right and the field is ready to accept and implement MUSA for better patient outcomes. In this project, we will tackle the remaining bottlenecks for succesful outroll of the product including upscaling and optimizing manufacturability, to allow for rapid market uptake of MUSA after the project. MicroSure will introduce MUSA in all parts of Europe before 2029, reaching major societal and economic impact.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Microsure BV | Son En Breugel | Netherlands | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI